Overview

Surfactant Lavage vs. Bolus Surfactant in Neonates With Meconium Aspiration

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The objective of this pilot study is to examine the feasibility and safety of performing a larger trial to assess outcomes following treatment of meconium aspiration syndrome with surfactant lavage compared to bolus surfactant. Specifically, we will determine if surfactant lavage results in a more rapid improvement in physiologic outcomes (e.g. pulmonary compliance), as well as clinical outcomes (e.g. length of time on mechanical ventilation).
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
The Hospital for Sick Children
Treatments:
Pulmonary Surfactants
Criteria
Inclusion Criteria:

- infants ≥ 36 weeks gestational age with evidence of meconium aspiration syndrome

- respiratory support (ventilator or CPAP) within 6 h of birth

- enrolment within 24 h of birth

- significant difficulty with oxygenation, as indicated by an oxygenation index (OI) >
15, where OI = (FiO2 x MAP) / PaO2 and MAP is the mean airway pressure

- presence of an arterial line

Exclusion Criteria:

- major congenital anomalies

- known antenatal diagnosis of significant congenital heart disease (diagnosis other
than patent foramen ovale, patent ductus arteriosus or small ventricular septal
defect)

- infants with a maternal history of oligohydramnios and physical features consistent
with the diagnosis

- surfactant administration prior to enrolment

- hemodynamic instability defined as intractable hypotension on more than 2 inotropes

- significant pulmonary hemorrhage, defined as pulmonary hemorrhage in association with
a 30% (absolute) increase in FiO2 and radiologic changes consistent with pulmonary
hemorrhage

- significant intracranial hemorrhage, defined as a unilateral or bilateral Grade III or
IV intraventricular hemorrhage or a large intracranial, non-intraventricular
hemorrhage

- significant illness meeting ECMO criteria with an OI > 40

- infants in whom withdrawal of intensive care is likely